Article, 2024

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes

DIABETES OBESITY & METABOLISM, ISSN 1462-8902, Volume 26, 5, Pages 1941-1949, 10.1111/dom.15510

Contributors

Hoevelmann, U. (Corresponding author) [1] [2] Engberg, Sara 0000-0002-1007-4092 [3] Heise, T. [2] Kristensen, N. R. [3] Norgreen, Lea [3] Zijlstra, Eric [2] Ribel-Madsen, Rasmus [3]

Affiliations

  1. [1] Ulrike Hovelmann, Hellersbergstr 9, D-41460 Neuss, Germany
    2. [NORA names: Germany; Europe, EU; OECD];
  2. [2] Profil, Neuss, Germany
    3. [NORA names: Germany; Europe, EU; OECD];
  3. [3] NOVO Nordisk, Soborg, Denmark
    4. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

basal insulin, insulin analogues, pharmacodynamics, pharmacokinetics, phase I-II study, type 1 diabetes

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+